Split-course radiotherapy: where do we stand?
Dubben HH, Krüll A, Beck-Bornholdt HP.
Strahlenther Onkol. 2001 May;177(5):227-39. doi: 10.1007/pl00002402.
Updated Outcomes of Split Course Radiotherapy in Elderly or Infirm Patients With Advanced Cancers of the Head and Neck.
Domb C, Smile TD, Reddy C, Woody NM, Campbell SR, Canavan JF, Joshi NP, Greskovich JF, Chute DJ, Burkey BB, Ku LA, Lamarre E, Lorenz RR, Prendes B, Scharpf J, Schwartzman L, Geiger JL, Koyfman SA, Fleming CW.
Anticancer Res. 2021 Oct;41(10):4995-5000. doi: 10.21873/anticanres.15313.
[Split-course radiotherapy or treatment interruption].
Feldmann HJ.
Strahlenther Onkol. 2000 Oct;176(10):458-61. doi: 10.1007/pl00002310.
Feasibility of split-course stereotactic ablative radiotherapy for oligometastases.
Paik EK, Kim MS, Seo YS, Jang WI, Kang JK, Cho CK, Yoo HJ.
Jpn J Clin Oncol. 2018 Jun 1;48(6):548-554. doi: 10.1093/jjco/hyy062.
Will personalized ultrafractionated stereotactic adaptive radiotherapy (PULSAR) or split-course SBRT based on systemic therapy (3S) be future directions in the Field of SBRT?
Zhou Z, Guan B, Lin J, Zheng R, Xu B.
Int Immunopharmacol. 2025 Jan 27;146:113689. doi: 10.1016/j.intimp.2024.113689. Epub 2024 Dec 24.
Split-course hypofractionated radiotherapy for aged and frail patients with head and neck cancers. A retrospective study of 75 cases.
Benhmida S, Sun R, Gherga E, Hammoud Y, Rouvier J, Mauvais O, Bockel S, Louvrier A, Lebbad A, Bontemps P, Ortholan C, Bourhis J, Lestrade L, Sun XS.
Cancer Radiother. 2020 Dec;24(8):812-819. doi: 10.1016/j.canrad.2020.03.013. Epub 2020 Nov 2.
Split-course radiotherapy of cancer.
Holsti LR.
Acta Radiol Ther Phys Biol. 1967 Aug;6(4):313-22. doi: 10.3109/02841856709138592.
Radical surgery and postoperative split-course radiotherapy in squamous cell carcinoma of the mobile tongue: factors influencing local control and the time to recurrence.
Kajanti M, Holsti LR, Holsti P.
Radiother Oncol. 1991 Nov;22(3):174-9. doi: 10.1016/0167-8140(91)90021-8.
Split-course palliative radiotherapy for advanced non-small cell lung cancer.
Metcalfe SK, Milano MT, Bylund K, Smudzin T, Rubin P, Chen Y.
J Thorac Oncol. 2010 Feb;5(2):185-90. doi: 10.1097/JTO.0b013e3181c6eb20.
Combining chemotherapy and tislelizumab with preoperative split-course hypofraction radiotherapy for locally advanced rectal cancer: study protocol of a prospective, single-arm, phase II trial.
Zheng R, Wang BS, Li Z, Chi P, Xu B.
BMJ Open. 2023 Mar 16;13(3):e066976. doi: 10.1136/bmjopen-2022-066976.
